Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) Ticker Search
Pro Search
Index Search
 QQQ: 72.76 -1.11%   SPY: 163.45 -1.38% FAQ | Sign Up Now | Login
Profile Portfolio Notes & Links Tracked By  


  Track this member and follow their portfolio moves with tickerspy™ alerts  

Stockavenue10


Portfolio List (390):
Art Deco Coastal City Uniquely New Zealand


Close
Cafe Pharma  0.0%
Laguna Beach  -0.7%
HPQ  -0.2%
Jet Set   -0.2%
Apres Ski  0.0%
Idyllic Isle  0.0%
Natural Gas   0.0%
Mine Watch B  0.0%
Playboy  0.0%
Rare Earth's  -5.9%
Coal Mines  -0.7%
Masterpiece  0.0%
Boom Town  0.0%
Mine Watch C  0.0%
Mali Gold   -3.3%
Coup D'Etat  0.0%
Products  0.0%
Agribusiness   -1.0%
China Stocks  -1.1%
China Fund  -4.6%
Mdav Fund  0.0%
Oil Bonanza  0.0%
Art Deco Coastal City Uniquely New Zealand  0.0%
Zplage  0.0%
Brazil Oil  -4.1%
Telecom   -1.0%
Rip 10  0.0%
Mine Watch  0.0%
Private Stock  -2.3%
Dee Gill Fund  -0.2%
Mining ETF's  -4.8%
MLP's  -7.9%
Mine Shaft  0.0%
Uranium Mines  -0.5%
Uranium  -0.5%
Hi Teck   -0.5%
Rare Earth  -4.0%
Eco Friendly  0.0%
French Bistro  -1.3%
Coal Mining  0.0%
Africa Gold  0.0%
St Tropez  0.0%
Club Zurich  -1.2%
Stock Oasis  0.0%
Stock Spa  0.0%
Stylish Mines  -2.8%
Clean Energy  0.0%
Africa Oil   0.0%
Eiffel Tower  -1.1%
Oil Services  -1.7%
Silver Mines  -3.1%
Digger Fund  0.0%
Stock Bonanza  -0.2%
Day Trader  0.2%
Royce Funds  0.1%
Stock Cafe  -0.5%
Oil Refinery  -0.9%
Media  0.0%
Oil Bistro  0.0%
Medical  -2.6%
Ease Of Life  0.0%
Roll The Dice  -0.5%
Wealth Fund  -1.5%
Texas Tea  0.0%
Oil Oasis  0.9%
Copper Mines  -1.5%
Petro Hunter  0.0%
Brazil Stocks  -4.0%
Bank Stocks  -1.2%
Black Gold  0.3%
Bakken Oil B  0.0%
Web Savvy   0.0%
Tinseltown  1.7%
Biotech C  4.8%
Paydirt Mines  -3.1%
Stock Chalet  0.0%
Movie Stocks  0.0%
World Fund   0.0%
Seine Paris  0.0%
Jouer Au M  -0.1%
Stock Buyer  -0.9%
Solar Stocks  0.0%
Biotech B  0.0%
Stock Chateau     0.0%

  Performance       Ideas       Community  
 
Today:
Week:
1-month:
All-time: 		0.0%
+11.1%
+0.8%
+4.9% 		vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500: 		+1.4%
+11.6%
+2.9%
-13.8%
     
Similar Portfolios also own:
C, F, BAC, MRO, AAPL, ABX, AIG, CSCO, SAN, AA
 
     
Share this portfolio on Facebook
Share this portfolio on Twitter
 
                     
     
 
Chart View
1 week
  
1 month
  
3 months
  
6 months
  
All Time
  
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Portfolio HistoryNEW    
Click a column to sort | Scroll over columns for more information
What are Alerts?
  
 Ticker Last Trade Today's Change Volume  % of
Daily		 Mkt Cap  Div Yield  % off
52wk lw		 % from
52wk hg		 Gain View as: Alerts Comments
 AERN $0.00 0.00 -66.7% 1,106,906 461% $77 - 0% -94% -97.9%
 AERS $0.00 0.00 0.0% 5,000 4% $ - 1033% -89% -64.2%
 ARGB $0.31 0.00 0.0% 100 3333% $7.1M - 24% -40% +171.3%
 CDID $0.00 0.00 0.0% 0% $ - 50% -98% +25.0%
 INLC $0.07 -0.02 -22.2% 21,129 82% $72.7K - -7% -99% +17.6%
 IRYS $0.00 0.00 0.0% 7,500 27% $82.9K - 16% -98% -99.2%
 JBII $0.44 -0.03 -6.4% 56,721 62% $42.2M - 52% -70% -61.4%
 MDAV $0.16 -0.04 -17.9% 3,975 202% $2.0M - 100% -54% +900.0%
 RAYS $0.00 0.00 -7.7% 6,933,098 27% $21.9M - 2300% -98% -99.4%
 RTWW $0.00 0.00 0.0% 1,088,036 24978% $ - 150% -79% +66.7%
 SMNG $0.00 0.00 0.0% 40,000 12012% $ - N/A% N/A% -99.3%
 SWRL $0.39 -0.39 -100.0% 5,000 64% $5.9M - 133% -7% +136.4%
 UNGS $0.00 0.00 0.0% 1,100,000 2% $36.0K - 0% -67% -87.5%
 WSML $0.04 0.00 0.0% 2,200 180% $8.8M - 218% -94% -82.5%
 ZGNX $1.56 +0.06 +4.0% 430,026 78% $151.2M - 41% -53% -20.0%
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss this portfolio with Stockavenue10
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Zogenix Announces Initiatives to Reach Key Business Milestones
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 05, 08:13AM from (globenewswire.com)
SAN DIEGO, June 5, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
U-Swirl Announces Results for 2013 "New" Fiscal Year
RMCF  SWRL  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 30, 09:03AM

HENDERSON, Nev., May 30, 2013 /PRNewswire/ -- U-Swirl,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Rocky Mountain Chocolate Factory, Inc. to Host FY2013 Operating Results Conference Call on Thursday, May 23, 2013
RMCF  SWRL  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 21, 08:12PM from (www2.marketwire.com)
Rocky Mountain Chocolate Factory, Inc. (NASDAQ: RMCF) today announced that it will host an investor conference call at 4:15  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix and Battelle to Present Positive, New Data Demonstrating Value of Needle-Free Injection for Biologics
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 20, 07:43AM from (globenewswire.com)
SAN DIEGO and COLUMBUS, Ohio, May 20, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) and Battelle Memorial Institute  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 03, 07:43AM from (globenewswire.com)
SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Reports Positive Top-Line Results From Extended Relday(TM) Phase 1 Clinical Trial
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 02, 07:43AM from (globenewswire.com)
SAN DIEGO, May 2, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Market Close: Big Winners & Losers for April 5, 2013
ISSC  BCRX  RIGL  NIHD  FFIV  RDWR  AQQ  ANCX  ZGNX  BVA  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - April 05, 04:26PM from (247wallst.com)
Here are today’s five biggest gaining stocks at closing: BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) is up 28.8% at $1.70.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix and Battelle Extend DosePro Co-Marketing Partnership
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - March 27, 08:13AM from (globenewswire.com)
SAN DIEGO and COLUMBUS, Ohio, March 27, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
JBI, Inc. Announces Conference Call to Discuss Operations and 2012 Year End Results
JBII  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - March 20, 07:14AM from (www2.marketwire.com)
JBI, Inc. (the "Company" or "JBI") (OTCQB: JBII), a clean energy company that recycles waste plastic  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2012 Financial Results
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - March 07, 07:43AM from (globenewswire.com)
SAN DIEGO, March 7, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Provides Update on Zohydro(TM) ER Regulatory Review
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 26, 08:13PM from (globenewswire.com)
SAN DIEGO, Feb. 26, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Announces Preliminary Fourth Quarter 2012 Gross Product Sales
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 07, 07:43AM from (globenewswire.com)
SAN DIEGO, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Reports Positive Results From Relday(TM) Phase 1 Clinical Trial
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 03, 07:43AM from (globenewswire.com)
SAN DIEGO, Jan. 3, 2013 (GLOBE NEWSWIRE) -- Zogenix Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Shares Plunge 52% on FDA Panel’s Turn-Down of Painkiller
ZGNX  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - December 10, 04:07PM from (ycharts.com)
A Food and Drug Administration panel voted not to recommend approval for a painkiller made by Zogenix (ZGNX), sending the  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Provides Update on FDA Advisory Committee Meeting for Zohydro(TM) ER for Management of Chronic Pain
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - December 07, 06:13PM from (globenewswire.com)
SAN DIEGO, Dec. 7, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Appoints New Chief Commercial Officer
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - November 26, 07:43AM from (globenewswire.com)
SAN DIEGO, Nov. 26, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix to Present at the 24th Annual Piper Jaffray Healthcare Conference
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - November 15, 08:13AM from (globenewswire.com)
SAN DIEGO, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Preliminary Findings From Rheumatoid Arthritis Patient Survey Reveal Strong Interest in Needle-Free Self-Injection
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - November 13, 07:13AM from (globenewswire.com)
COLUMBUS, Ohio and SAN DIEGO, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Battelle, the world's largest independent research and development  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - November 08, 09:43AM from (globenewswire.com)
SAN DIEGO, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - October 25, 08:13AM from (globenewswire.com)
SAN DIEGO, Oct. 25, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6



Home | About | Register | My tickerspy | Logout Web site design by LightMix
© 2007-2013 Indie Research, LLC. All rights reserved.  

 

---
The information herein is provided by various sources including individual contributors not associated with Indie Research and is not guaranteed by us and does not purport to be a complete or error-free statement or summary of the available data. As such, we do not warrant, endorse or guarantee the completeness, accuracy, integrity or timelines of the information. You must evaluate, and bear all risks associated with, the use of any information provided hereunder, including any reliance on the accuracy, completeness, safety or usefulness of such information. This information is not intended to be used as the primary basis of investment decisions. It should not be construed as financial or other advice or as an offer to sell or the solicitation of an offer to buy any security in any state where such an offer or solicitation would be illegal. Any information expressed herein on this date is subject to change without notice. Any opinions or assertions contained in this information do not represent the opinions or beliefs of Indie Research, LCC or one or more of its employees, may have a position in any of the securities discussed herein. Use of the tickerspy.com, signifies your agreement to the Terms of Use.

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.


Market Data Powered by Interactive Data
Terms and Conditions

Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.
Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.
Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.
Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.
Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.
Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.
Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.
Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.